1 active not recruiting, 1 not yet recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Not yet recruiting 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Keratoderma, Palmoplantar: new trials by email Literature Review of Keratoderma, Palmoplantar trials Research Report on Keratoderma, Palmoplantar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Epidermal Growth Factor Receptor Inhibition for Keratinopathies Erlotinib - Epidermolytic Ichthyosis, Palmoplantar Keratoderma | Phase 1 / Phase 2 | Not yet recruiting | Northwestern University | 44 | 2027-07-01 | 2026-08-03 |
| Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma Tapinarof - Palmoplantar Keratoderma | Phase 2 | Active not recruiting | Indiana University | 6 | 2024-10-30 | 2026-06-23 |
Hyperkeratosis, Epidermolytic (1) · Pachyonychia Congenita (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Keratosis (2) · Skin Diseases (2) · Skin Diseases, Genetic (2) · Skin and Connective Tissue Diseases (2) · Abnormalities, Multiple (1) · Congenital Abnormalities (1) · Ectodermal Dysplasia (1) · Ichthyosiform Erythroderma, Congenital (1) · Ichthyosis (1) · Infant, Newborn, Diseases (1) · Nail Diseases (1) · Skin Abnormalities (1)
Erlotinib Hydrochloride (1) · tapinarof (1)
Indiana University (1) · Northwestern University (1)
United States (2)
Amy Paller (1) · David Rosmarin, MD (1)